HIV Symposium: HIV Cure and Latency
| Thursday, November 19, 2020 |
| 4:00 PM - 5:27 PM |
Overview
Antiretroviral therapy (ART) can suppress HIV to undetectable levels in blood, however despite ongoing treatment, the virus can persist in latent viral reservoirs, which is one of the largest obstacles to finding a HIV cure. This symposium discusses the most recent technologies that are being used to characterize these latent reservoirs and current cutting-edge approaches that are being investigated to eliminate them.
Speaker
Professor Sarah Palmer
Co-Director of the Centre for Virus Research at The Westmead Institute for Medical Research and Professor in the Faculty of Medicine and Health at the University of Sydney School of Medicine
Westmead Institute For Medical Research
Studies of full-length HIV DNA: What have we learned?
Biography
Prof Palmer’s research focuses on molecular and medical virology and the application of innovative techniques and assays which provide new insights into disease pathogenesis and treatment, for HIV and COVID-19. She received her Ph.D. in Medical Sciences (Virology) from the Karolinksa Institutet, and conducted her post-doctoral studies at the Center for AIDS Research, Stanford University Medical School.
Dr Chantelle Ahlenstiel
Senior Research Fellow
Kirby Institute UNSW Sydney
RNA-directed epigenetic silencing protects humanised mice during HIV challenge
Biography
Dr Ahlenstiel is a Senior Research Fellow at the Kirby Institute. She leads the RNA Silencing research group, who develop and investigate novel antiviral RNA targeting a range of viruses, including HIV-1 and SARS-CoV-2.
Dr. Thomas Rasmussen
Associate Clinical Director, HIV Cure Studies
Doherty Institute, University of Melbourne
Immunotherapeutic approaches to eliminate HIV persistence on ART
Biography
Thomas Aagaard Rasmussen is a physician and clinical researcher from The Peter Doherty Institute for Infection and Immunity, University of Melbourne. He is actively engaged in clinical and translational studies focused on understanding HIV persistence on antiretroviral therapy and with a key interest in therapeutic strategies for HIV cure and remission.
Discussion
Discussion
Biography
Co-chair
Jori Symons
Stuart Turville
The Kirby Institute, UNSW Sydney
Speaker
Chantelle Ahlenstiel
Senior Research Fellow
Kirby Institute UNSW Sydney
Sarah Palmer
Co-Director of the Centre for Virus Research at The Westmead Institute for Medical Research and Professor in the Faculty of Medicine and Health at the University of Sydney School of Medicine
Westmead Institute For Medical Research
Thomas Rasmussen
Associate Clinical Director, HIV Cure Studies
Doherty Institute, University of Melbourne
Support Staff
Brooke McClune
Touchpoint
Linda Starke
Event Coordinator
ASHM
